{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:26:37Z","timestamp":1795026397092,"version":"4.10.2"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Drug-induced deaths, defined as intentional or unintentional consumption of illicit substances or diverted medications leading to death, are the leading cause of death for reproductive-age women in the United States. Our objective was to describe pregnancy-associated deaths attributed to drug-induced causes to identify opportunities for intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Using the Utah Perinatal Morality Review Committee database, we performed a retrospective cohort study of all pregnancy-associated deaths\u2014death of a woman during pregnancy or within 1 year from the end of pregnancy\u2014from 2005 to 2014. We performed a detailed descriptive analysis of women with drug-induced deaths. We compared characteristics of women with drug-induced and other pregnancy-associated deaths.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      From 2005 to 2014, 136 pregnancy-associated deaths were identified. Drug-induced death was the leading cause of pregnancy-associated death (n=35, 26%) and 89% occurred in the postpartum period. More specifically, those with a drug-induced death were more likely to die in the late postpartum period, defined as death occurring within 43 days to 1 year of the end of the pregnancy, (n=28\/35, 80%) compared with women whose deaths were from other pregnancy-associated causes (n=34\/101, 34%) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;.001). The majority of drug-induced deaths were attributed to opioids (n=27\/35, 77%), prescription opioids (n=21\/35, 60%), and polysubstance use (n=29\/35, 83%). From 2005 to 2014, the pregnancy-associated mortality ratio increased 76%, from 23.3 in 2005 to 41.0 in 2014. During this same time period, the drug-induced pregnancy-associated mortality ratio increased 200%, from 3.9 in 2005 to 11.7 in 2014.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Drug-induced death is the leading cause of pregnancy-associated death in Utah and occurs primarily in the late postpartum period. Interventional studies focused on identifying and treating women at risk of drug-induced death are urgently needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003279","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T06:03:55Z","timestamp":1557727435000},"page":"1131-1140","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":115,"title":["Pregnancy-Associated Death in Utah"],"prefix":"10.1097","volume":"133","author":[{"given":"Marcela C.","family":"Smid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Baksh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle P.","family":"Debbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett D.","family":"Einerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Varner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A. S.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20261118","first-page":"1","article-title":"Deaths: final data for 2015","volume":"66","author":"Murphy","year":"2017","journal-title":"Natl Vital Stat Rep"},{"key":"R3-20261118","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132015","volume":"273","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"key":"R4-20261118","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-20261118","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization\u2014United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R6-20261118","first-page":"1216","article-title":"Patterns of opioid utilization in pregnancy in a large cohort of commercial insurance beneficiaries in the United States","volume":"120","author":"Bateman","year":"2014","journal-title":"J Am Soc Anesthesiolo"},{"key":"R7-20261118","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among medicaid-enrolled women","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R10-20261118","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2015.02.027","article-title":"Perinatal substance use: a prospective evaluation of abstinence and relapse","volume":"150","author":"Forray","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"R11-20261118","first-page":"374","article-title":"Pregnancy-related substance use in the United States during 1996\u20131998","volume":"101","author":"Ebrahim","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R12-20261118","first-page":"143","article-title":"Association of clinical characteristics and cessation of tobacco, alcohol, and illicit drug use during pregnancy","volume":"20","author":"Massey","year":"2011","journal-title":"Am J Addict"},{"key":"R13-20261118","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2006.06.015","article-title":"Mood disorders affect drug treatment success of drug-dependent pregnant women","volume":"32","author":"Fitzsimons","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"R14-20261118","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/AOG.0000000000002734","article-title":"Fatal and nonfatal overdose among pregnant and postpartum women in Massachusetts","volume":"132","author":"Schiff","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R15-20261118","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajog.2018.09.028","article-title":"Trends in pregnancy-associated mortality involving opioids in the United States, 2007\u20132016","volume":"220","author":"Gemmill","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20261118","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/AOG.0000000000001695","article-title":"Maternal deaths from suicide and overdose in Colorado, 2004\u20132012","volume":"128","author":"Metz","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R17-20261118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13722-018-0126-0","article-title":"Frequency and associated risk factors of non-fatal overdose reported by pregnant women with opioid use disorder","volume":"13","author":"Bagley","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"R24-20261118","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/AOG.0000000000001456","article-title":"Pregnancy-associated deaths in rural, nonrural, and metropolitan areas of Georgia","volume":"128","author":"Platner","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R25-20261118","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R27-20261118","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/AOG.0000000000002633","article-title":"Optimizing postpartum care. ACOG Committee Opinion No. 736. American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R28-20261118","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1891\/1058-1243.23.1.9","article-title":"Major survey findings of Listening to Mothers(SM) III: pregnancy and birth: report of the third National US survey of women's childbearing experiences","volume":"23","author":"Declercq","year":"2014","journal-title":"J Perinatal Educ"},{"key":"R29-20261118","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/AOG.0b013e3181a5ec6f","article-title":"Methamphetamine use among pregnant women","volume":"113","author":"Terplan","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R30-20261118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/ADM.0000000000000101","article-title":"Methamphetamines and pregnancy outcomes","volume":"9","author":"Wright","year":"2015","journal-title":"J Addict Med"},{"key":"R31-20261118","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/AOG.0000000000002407","article-title":"Opioid knowledge and prescribing practices among obstetrician\u2013gynecologists","volume":"131","author":"Madsen","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R32-20261118","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/AOG.0000000000002881","article-title":"Prenatal treatment and outcomes of women with opioid use disorder","volume":"132","author":"Brogly","year":"2018","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201906000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:02:55Z","timestamp":1795024975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201906000-00009"}},"subtitle":["Contribution of Drug-Induced Deaths"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003279","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"2018-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}